Atopic dermatitis (AD) is a chronic or chronically relapsing inflammatory skin disease which
results from a complex, multifaceted interaction between environmental factors in genetically …

Atopic dermatitis (AD) is a chronic inflammatory skin disease that is characterized by
complex pathophysiology involving both skin barrier dysfunction and aberrant type 2 …

Although atopic dermatitis (AD) is primarily a Th2-driven disease, it shows high
heterogeneity with additional variable contributions of the Th22, Th17, and Th1 pathways …

Atopic dermatitis (AD) is characterized by type 2 helper T (Th2) cell-driven inflammation.
Dupilumab is a fully human monoclonal antibody directed against the IL-4 receptor α subunit …

Background: Atopic dermatitis (AD) can be debilitating and often requires the use of
combination topical and systemic therapy to achieve adequate disease control. Methods: A …

Atopic dermatitis (AD) is among the most common inflammatory skin diseases in children
and adults in industrialized countries. Up to one-third of adults (probably a smaller …

Atopic dermatitis (AD) is a chronic inflammatory skin condition marked by intensely pruritic,
eczematous changes. First-line therapy includes topical corticosteroids during an …

Introduction: Atopic dermatitis (AD) is a heterogeneous disease. Recent advancements in
understanding AD pathogenesis resulted in the exponential expansion of its therapeutic …

Atopic dermatitis (AD), a common chronic pruritic inflammatory skin disease, impacts the
quality of life of patients and caregivers and has become a global health problem. It is …

Atopic dermatitis (AD) is the most common chronic inflammatory disease affecting 2-10% of
adults and up to 15-30% of children. Despite a rising prevalence, effective and safe …